Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic PDF $40.00
$40.00
× Placeholder The Effectiveness of Quetiapine Versus Conventional Antipsychotics in Improving Cognitive and Functional Outcomes in Standard Treatment Settings PDF $40.00
$40.00
× Placeholder The Role of Glucagon-Like Peptide-1 Receptor Agonists in Alcohol Use Disorder PDF $40.00
$40.00
× Placeholder The Impact of Attempted Suicide on the Symptoms and Course of Mood Disorders PDF $40.00
$40.00
× Placeholder Pilot Trial of Ondansetron in the Treatment of 8 Patients With Obsessive-Compulsive Disorder PDF $40.00
$40.00
× Placeholder Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe